跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 25,633 条关于
“recombinant C1 esterase inhibitor”
全部
25,633
临床试验
13,031
药物
5,903
机构
43
资讯
6,656
11个月前
Pharming Group to Present 12 Studies on Rare Disease Treatments at 2025 ACAAI Meeting
去年
European Patent Board Revokes C1-Esterase Inhibitor Patent for Kidney Transplant Rejection Treatment
2个月前
Dyadic Secures Japanese Patent for C1 Recombinant Protein Platform, Accelerates Asia-Pacific Expansion
2个月前
Dyadic's C1 Platform Gains Momentum as Ebola Outbreak Highlights Urgent Need for Rapid Biologics Manufacturing
去年
KalVista to Present Sebetralstat Data at Major Medical Conferences as FDA Review Continues
9个月前
Dyadic Applied BioSolutions Expands Strategic Partnerships to Accelerate Commercial Growth of Recombinant Protein Portfolio
去年
FDA Delays Sebetralstat Approval Decision for Hereditary Angioedema Treatment Due to Resource Constraints
去年
KalVista's Sebetralstat Halts Hereditary Angioedema Attacks in Median 19.8 Minutes Across Clinical Trials
2年前
KalVista Submits NDA to FDA for Oral Sebetralstat in Hereditary Angioedema
去年
CEPI Awards $4.5 Million to Accelerate Vaccine Development Using Dyadic's C1 Fungal Platform
第 1 页，共 666 页
上一页
下一页
